Agree with Angelus; this will continue until Msb have recurring income and dividends to unpin the shareprice with some fundamentals. It's a free market to all. if you are going to write a letter suggest it is to Teva and Msb for the unexplained 2 year delay on their most advanced indication, Recascor. Teva recent comments suggesting the chf phase 3 will quite possibly be canned after a quick 125 person trial is not very comforting to the market. for msb's next deal lets hope they are more thorougb in the drafting of the terms.
was there a bad ann. since thur. , page-17
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.43 | $4.048M | 2.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 26808 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 16001 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |